BioMarin· @BioMarin · X·· 15 天前AI 评分37
AI 导读
今天我们向投资者社区公布了2026年第三季度业绩,总营收较去年同期同比增长32%。这得益于全球对我们药品的强劲潜在需求。 更多内容请阅读我们的新闻稿:http://ms.spr.ly/6012aNoIG $BMRN
正文
Today we announced Q3 2026 results to the investor community, including a 32% year-over-year increase in total revenues compared to the same quarter last year. This was driven by strong underlying demand for our medicines around the world.
Read more in our press release: http://ms.spr.ly/6012aNoIG
$BMRN
来源:BioMarin · x.com